ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,139.83
0.75%
Dow Jones
38,239.66
0.40%
Gold vs US Dollar
2,337.935
0.30%
Brent Oil
88.165
0.02%
Bitcoin
63,876.64
-0.94%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Shield Therapeutics Plc (STX) Share Price

STX Shield Therapeutics Plc

1.35
0.125 (10.20%)
26 Apr 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Shield Therapeutics Plc LSE:STX London Stock Exchange Ordinary Share GB00BYV81293 ORD 1.5P
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.125 10.20 1.35 1.30 1.40 1.35 1.20 1.225 8,345,835 15:20:04   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.26 10.47M
 Type  Size  Price  Time  Units 
  175,000 1.35 16:06:27 GBX
 
Recent News
DateTimeSource
HeadlineMore STX News
16/04/202407:00LSEG_RNSShield Therapeutics PLC Notice of Results
21/02/202412:36ALNCShield Therapeutics sinks as strong performance marred by data issues
21/02/202407:00LSEG_RNSShield Therapeutics PLC Unaudited Full Year Trading Update
09/01/202411:33ALNCIN BRIEF: Shield Therapeutics hires former Akili leader as new CFO
09/01/202407:00UKREGShield Therapeutics PLC Appointment of new Chief Financial Officer
07/12/202315:31ALNCTRADING UPDATES: Comptoir opens restaurant; Intercede wins contract
07/12/202307:00UKREGShield Therapeutics PLC Q3 2023 U.S. Commercial Highlights
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
26/04/202416:09PBBShield Therapeutics: poised for a US licensing deal13,702
28/02/202413:05PBBShield Therapeutics 4,112
22/02/202408:59PBBShield therapeutics what next?1,975
22/02/202408:37PBBShield Therapeutics: Poised for a US deal2
12/04/202310:06PBBShorted to 10p455
26/02/202320:38PBBSeagate Technology2,683
15/06/202217:04PBBSYNECTICS345
Newsletter articles for Shield Therapeutics Plc
DateTimeNewsletterHeadline
18/12/202219:32Opportunity 4 Material Gains2022 Lens Clearing
11/9/202220:48Opportunity 4 Material GainsTime slows
04/9/202217:34Opportunity 4 Material GainsBetter than bad
10/6/202208:09Tom Winnifrith's N50The short letter from Tom Winnifrith: Each morning Shield Therapeutics disappoints me
14/3/202207:57Tom Winnifrith's N50The Short Letter from Tom Winnifrith: It’s safer to stick to small caps as a bear and this is the next Omega
More newsletter articles
Data Downloads for STX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)
Technical Analysis for Shield Therapeutics Plc
Get quick technical analysis for Shield Therapeutics Plc.
Price Indicators
Evaluate in real-time the trend for this stock with base on twelve different studies.
Candlesticks
Verify the trend for the closing and opening times for this stock or defined reversal patterns.
Support & Resistance
Automatically plot the main lines for support and resistance for this tock highlighting the main levels.
Related Shares
Astrazeneca (AZN), Gsk (GSK), N4 Pharma (N4P), Fusion Antibodies (FAB)


Loading Follow Feed...

Latest Shield Therapeutics Plc Articles